Glaxo Seeks Ban on Ranbaxy's Herpes Drug

Law360, New York (February 2, 2007, 12:00 AM EST) -- Pharmaceutical giant GlaxoSmithKline wants a preliminary injunction banning generic drug manufacturer Ranbaxy Laboratories from launching a version of its herpes treatment in the U.S.

The British drug maker claims the two companies had a prior agreement whereby Glaxo could apply to the court for an injunction order within 45 days of its rival’s winning bid to market its generic equivalent.

Under the terms of the deal, previously approved by the court, Ranbaxy Pharmaceuticals agreed not to launch its product until a judge ruled either on the...
To view the full article, register now.